CSIMarket
 


Sophiris Bio Inc.  (SPHS)
Other Ticker:  
 
 

SPHS's Income from Cont. Operations Growth by Quarter and Year

Sophiris Bio's Income from Cont. Operations results by quarter and year




SPHS Income from Cont. Operations (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 5.52 -3.97 -0.55
III Quarter September -0.96 -2.87 -2.65 -4.28
II Quarter June -2.16 -6.10 0.61 -4.09
I Quarter March -2.36 -3.33 -2.62 -2.24
FY   -5.48 -6.78 -8.63 -11.16



SPHS Income from Cont. Operations third quarter 2019 Y/Y Growth Comment
Sophiris Bio Inc. in the third quarter 2019 recorded loss from continued operations of $ -0.96 millions.

According to the results reported in the third quarter 2019, Sophiris Bio Inc. achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Sophiris Bio Inc.' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2019.




SPHS Income from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Sophiris Bio's third quarter 2019 Income from Cont. Operations $ -0.96 millions SPHS's Income Statement
Sophiris Bio's third quarter 2018 Income from Cont. Operations $ -2.87 millions Quarterly SPHS's Income Statement
New: More SPHS's historic Income from Cont. Operations Growth >>


SPHS Income from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Sophiris Bio's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SPHS's III. Quarter Q/Q Income from Cont. Operations Comment
Although Sophiris Bio Inc. in the III. Quarter 2019 admitted loss from continued operations of $ -0.96 millions, management point out, that those numbers are slight up side relative to the -2.16 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Sophiris Bio Inc. achieved highest sequential Income from Cont. Operations growth. While Sophiris Bio's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SPHS's III. Quarter Q/Q Income from Cont. Operations Comment
Although Sophiris Bio Inc. in the III. Quarter 2019 showed loss from continued operations of $ -0.96 millions, management mentioned, that those numbers show recovery compare to the -2.16 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Sophiris Bio Inc. achieved highest sequential Income from Cont. Operations growth. While Sophiris Bio's Income from Cont. Operations growth quarter on quarter, overall rank is .


Sophiris Bio's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Income from Cont. Operations 12 Months Ending $ 0.04 $ -1.88 $ -5.81 $ -6.78 $ -16.26
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
In the Sep 30 2019 period, Sophiris Bio had cumulative twelve months Income from Cont. Operations of $ 0 millions compare to loss from continued operations of $ -16 millions a year ago.

Sophiris Bio Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
In the Sep 30 2019 period, Sophiris Bio had cumulative twelve months Income from Cont. Operations of $ 0 millions compare to loss from continued operations of $ -16 millions a year ago.

Sophiris Bio Inc. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
SPHS's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for SPHS's Competitors
Income from Cont. Operations Growth for Sophiris Bio's Suppliers
Income from Cont. Operations Growth for SPHS's Customers

You may also want to know
SPHS's Annual Growth Rates SPHS's Profitability Ratios SPHS's Asset Turnover Ratio SPHS's Dividend Growth
SPHS's Roe SPHS's Valuation Ratios SPHS's Financial Strength Ratios SPHS's Dividend Payout Ratio
SPHS's Roa SPHS's Inventory Turnover Ratio SPHS's Growth Rates SPHS's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2019
Quest Diagnostics Inc-0.44%$ -0.441 millions
Dexcom Inc -1.72%$ -1.717 millions
Merck and Co Inc -2.60%$ -2.605 millions
Procyon Corporation-3.94%$ -3.941 millions
Innoviva Inc -6.21%$ -6.211 millions
American Renal Associates Holdings Inc -6.93%$ -6.926 millions
Acadia Healthcare Company Inc -7.68%$ -7.684 millions
National Healthcare Corp-8.11%$ -8.114 millions
Radnet Inc -11.80%$ -11.796 millions
Masimo Corp-14.08%$ -14.076 millions
Hca Healthcare Inc -14.73%$ -14.732 millions
Bio techne Corp-17.27%$ -17.267 millions
Pro dex Inc -18.16%$ -18.162 millions
Stryker Corp-21.02%$ -21.017 millions
Zynex inc -21.54%$ -21.536 millions
Magellan Health inc -21.63%$ -21.628 millions
Revvity Inc -22.63%$ -22.630 millions
Ani Pharmaceuticals Inc-22.67%$ -22.672 millions
Exelixis Inc -23.04%$ -23.042 millions
Meridian Bioscience Inc -24.49%$ -24.494 millions
Bristol myers Squibb Company-28.56%$ -28.556 millions
Healthcare Services Group Inc -29.68%$ -29.679 millions
Horizon Therapeutics Public Limited Company-29.95%$ -29.950 millions
Laboratory Corporation Of America Holdings-30.72%$ -30.721 millions
Nuvasive Inc-30.85%$ -30.855 millions
Baxter International Inc -31.07%$ -31.066 millions
Abbvie inc -31.42%$ -31.416 millions
Jazz Pharmaceuticals Plc-31.50%$ -31.504 millions
Amphastar Pharmaceuticals Inc -39.11%$ -39.109 millions
Universal Health Services Inc -42.32%$ -42.321 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com